Dosages for treatment with anti-ErbB2 antibodies | Patent Number 07371379

US 07371379 B2
Application Number10600152
Publication NumberUS 20040037824 A1
Pendency4 years, 10 months, 29 days
Filled DateJun 20, 2003
Priority DateAug 27, 1999
Publication DateFeb 26, 2004
Expiration DateAug 27, 2019
Inventor/ApplicantsSharon A. Baughman
Steven Shak
Steven Shak
Sharon A. Baughman
ExaminesHOLLERAN, ANNE L
Art Unit1643
Technology Center1600
Assignments
Roche
Current
Genentech IncRoche
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.